Tuesday, December 15, 2009   


Worrying stock notice

Tuesday, June 30, 2009

A public announcement of a Hong Kong-listed micro cap company (Benefun International (1130)) was made last week on the HKEx website and probably went unnoticed by the public. However, the implication of its content is huge and could have significant impact on the Hong Kong stock market.

The announcement was about certain minority shareholders suing the com Para 2.2 Line 0.2 pany for refusing share transfers. It looks like a commercial dispute from first glance, but a closer look will find a statement that could turn the stock market upside down. The company stated that pursuant to the company's articles, it has two months to consider any share transfer lodged with the share registrar.

ADVERTISEMENT

Wait! All listed companies in Hong Kong adopt more or less identical articles Para 2.2 Line 0.2 and that means all share transfers of listed shares need the blessing of the listed company and can be easily delayed by the company for two months!

So next time, if you vote against any resolutions or do anything that annoys the controlling shareholder or the directors, be prepared that your shares might not be sold in the stock market any time you want. It is also fantastic news for all controlling shareholders, you can easily restrict the transfer of all minority shareholders for two months and any buy order will send the share price of your company rocketing.

And, of course, for all investors, this liquidity risk will also be your key consideration before you decide to put money in the Hong Kong stock market.

S K Wong


© 2009 The Standard, The Standard Newspapers Publishing Ltd..
Contact Us | About Us | Newsfeeds | Subscriptions | Print Ad. | Online Ad. | Street Pts

 


Home | Top News | Local | Business | China | ViewPoint | CityTalk | World | Sports | People | Central Station | Features

The Standard

Trademark and Copyright Notice: Copyright 2005, The Standard Newspaper Publishing Ltd., and its related entities. All rights reserved.  Use in whole or part of this site's content is prohibited.   Use of this Web site assumes acceptance of the
Terms of Use and Copyright Policy.  Please also read our Ethics Statement.